Ionis Pharmaceuticals Inc financial data

Symbol
IONS on Nasdaq
Industry
Pharmaceutical Preparations
Location
2855 Gazelle Court, Carlsbad, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
ISIS PHARMACEUTICALS INC (to 12/18/2015)
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 808 % +8.85%
Quick Ratio 8.01 % +38.8%
Debt-to-equity 537 % -14.5%
Return On Equity -90.8 % -8475%
Return On Assets -15.7 % -26.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 159M shares
Common Stock, Shares, Outstanding 158M shares +9.4%
Entity Public Float 5.74B USD +35.2%
Common Stock, Value, Issued 158K USD +9.72%
Weighted Average Number of Shares Outstanding, Basic 150M shares +4.42%
Weighted Average Number of Shares Outstanding, Diluted 150M shares +4.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 227M USD -30.2%
Revenue from Contract with Customer, Excluding Assessed Tax 705M USD -10.5%
Costs and Expenses 1.18B USD +3.4%
Operating Income (Loss) -475M USD -34.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -460M USD -37.8%
Income Tax Expense (Benefit) -6.17M USD -119%
Net Income (Loss) Attributable to Parent -454M USD -23.9%
Earnings Per Share, Basic -3.04 USD/shares -18.8%
Earnings Per Share, Diluted -3.04 USD/shares -18.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 242M USD -39.4%
Inventory, Net 12.5M USD +68.1%
Other Assets, Current 218M USD +6.09%
Assets, Current 2.62B USD -0.82%
Property, Plant and Equipment, Net 94.3M USD +32.7%
Operating Lease, Right-of-Use Asset 162M USD -5.84%
Other Assets, Noncurrent 127M USD +20.9%
Assets 3B USD +0.46%
Accounts Payable, Current 43M USD +65.1%
Employee-related Liabilities, Current 69.6M USD +2.79%
Accrued Liabilities, Current 108M USD -26.7%
Contract with Customer, Liability, Current 79M USD -47.7%
Liabilities, Current 309M USD -31%
Contract with Customer, Liability, Noncurrent 157M USD -35.1%
Operating Lease, Liability, Noncurrent 162M USD -5.31%
Other Liabilities, Noncurrent 41.7M USD -14.5%
Liabilities 2.42B USD -7.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -30.8M USD +5.62%
Retained Earnings (Accumulated Deficit) -2.25B USD -25.3%
Stockholders' Equity Attributable to Parent 588M USD +52.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 315M USD -46.9%
Liabilities and Equity 3B USD +0.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -150M USD -11.9%
Net Cash Provided by (Used in) Financing Activities 23.6M USD -95.2%
Net Cash Provided by (Used in) Investing Activities 76.1M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 158M shares +9.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.4M USD -255%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 242M USD -39.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 95K USD +6.74%
Deferred Tax Assets, Valuation Allowance 1.13B USD +15.6%
Deferred Tax Assets, Gross 1.17B USD +14.5%
Operating Lease, Liability 171M USD -4.53%
Depreciation 2.55M USD -2.19%
Payments to Acquire Property, Plant, and Equipment 4.49M USD -57.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -452M USD -32.4%
Lessee, Operating Lease, Liability, to be Paid 260M USD -6.9%
Operating Lease, Liability, Current 9.06M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 21M USD +1.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.9M USD +2.31%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 89.4M USD -11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.1M USD +1.31%
Deferred Tax Assets, Operating Loss Carryforwards 95.9M USD +22.9%
Unrecognized Tax Benefits 41.2M USD -4.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21M USD +0.83%
Amortization of Intangible Assets 639K USD +5.27%
Share-based Payment Arrangement, Expense 130M USD +23.1%
Interest Expense 17M USD +34.2%